Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATShares Issued
Ratios

Terns Pharmaceuticals (TERN) Leases (2022 - 2023)

Terns Pharmaceuticals' Leases history spans 2 years, with the latest figure at $671000.0 for Q3 2023.

  • For Q3 2023, Leases fell 43.8% year-over-year to $671000.0; the TTM value through Sep 2023 reached $671000.0, down 43.8%, while the annual FY2022 figure was $1.0 million, N/A changed from the prior year.
  • Leases reached $671000.0 in Q3 2023 per TERN's latest filing, down from $756000.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $1.4 million in Q1 2022 to a low of $671000.0 in Q3 2023.